In the current evidence, the large heterogeneity between studies and the lack of striking RCT studies conducted considering specific populations defined on the basis of ethnicity, age, or sex, should be rectified so that the complexity of BDNF in severe cardiovascular disease and/or comorbidities (e.g., depression) can be clarified. The gene discussed is BDNF; the disease is depressive disorder.